Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Suisse (CSUI) EBT (2016 - 2025)

Cannabis Suisse (CSUI) has disclosed EBT for 10 consecutive years, with $22392.0 as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 342.35% to $22392.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $110181.0, a 106.9% increase, with the full-year FY2025 number at -$456142.0, up 61.56% from a year prior.
  • EBT was $22392.0 for Q4 2025 at Cannabis Suisse, up from $13907.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $57791.0 in Q2 2022 to a low of -$999085.0 in Q2 2024.
  • A 5-year average of -$113830.9 and a median of -$61625.5 in 2021 define the central range for EBT.
  • Peak YoY movement for EBT: crashed 1386.38% in 2024, then skyrocketed 342.35% in 2025.
  • Cannabis Suisse's EBT stood at -$73180.0 in 2021, then surged by 58.94% to -$30050.0 in 2022, then tumbled by 82.35% to -$54797.0 in 2023, then surged by 109.24% to $5062.0 in 2024, then surged by 342.35% to $22392.0 in 2025.
  • Per Business Quant, the three most recent readings for CSUI's EBT are $22392.0 (Q4 2025), $13907.0 (Q3 2025), and $44367.0 (Q2 2025).